<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) arises from the <z:mpath ids='MPATH_458'>normal</z:mpath> colon epithelium through the accumulation of genetic mutations and epigenetic alterations that are associated with progression along the histological <z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
<SENT sid="1" pm="."><plain>Elucidating the molecular alterations underlying disease progression will not only provide insight into the behavior of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, but also could lead to the discovery of useful biomarkers for diagnosis, monitoring treatment responsiveness, or predicting disease outcomes </plain></SENT>
<SENT sid="2" pm="."><plain>In the past a few years, there have been several evaluating differentially expressed protein biomarkers by employing proteomics technologies coupled with mass spectrometry </plain></SENT>
<SENT sid="3" pm="."><plain>In the current review, we will briefly summarize the results from selected recent studies using tissue or serum samples from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients in the past 5 years and discuss the opportunities and challenges in translating these findings from the research setting to clinical practice </plain></SENT>
</text></document>